CX-621

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCX-621

Drug Alias NameCx-621

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTigenix Nv

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTigenix Nv

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A